Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Morbidity control"'
Autor:
Klodeta Kura, Robert J. Hardwick, James E. Truscott, Jaspreet Toor, T. Deirdre Hollingsworth, Roy M. Anderson
Publikováno v:
Parasites & Vectors, Vol 13, Iss 1, Pp 1-10 (2020)
Abstract Background Schistosomiasis remains an endemic parasitic disease causing much morbidity and, in some cases, mortality. The World Health Organization (WHO) has outlined strategies and goals to combat the burden of disease caused by schistosomi
Externí odkaz:
https://doaj.org/article/937a499657344806a3927176636fc63e
Autor:
Toor, Jaspreet, Alsallaq, Ramzi, Truscott, James E., Turner, Hugo C., Werkman, Marleen, Gurarie, David, King, Charles H., Anderson, Roy M.
Publikováno v:
Clinical Infectious Diseases, 2018 Jun . 66, S245-S252.
Externí odkaz:
https://www.jstor.org/stable/26526073
Autor:
NR de Silva
Publikováno v:
Sri Lankan Journal of Infectious Diseases, Vol 8, Iss 2, Pp 60-68 (2018)
The major soil-transmitted helminth (STH) infections caused by Ascaris lumbricoides, Trichuris trichiura and Necator americanus have been recognized as endemic in Sri Lanka for over a century. Although prevalence rates have declined drastically over
Externí odkaz:
https://doaj.org/article/85f0bfb2e75743299a2200cd6ac08548
Publikováno v:
Infectious Diseases of Poverty, Vol 6, Iss 1, Pp 1-9 (2017)
Abstract Background Historically, the target in the schistosomiasis control has shifted from infection to morbidity, then back to infection, but now as a public health problem, before moving on to transmission control. Currently, all endemic countrie
Externí odkaz:
https://doaj.org/article/bbfd2c6afd034f0b87cc1437b389c383
Publikováno v:
Infectious Diseases of Poverty, Vol 6, Iss 1, Pp 1-10 (2017)
Abstract The current approach of morbidity control of schistosomiasis, a helminth disease of poverty with considerable public health and socioeconomic impact, is based on preventive chemotherapy with praziquantel. There is a pressing need for new dru
Externí odkaz:
https://doaj.org/article/ca71dc4e15cd4763af9cb5059c4d06ec
Autor:
Matt Graham, Jaspreet Toor, Klodeta Kura, Diepreye Ayabina, Roy M. Anderson, T. Déirdre Hollingsworth
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
S145
S140
S145
S140
Background The World Health Organization previously set goals of controlling morbidity due to schistosomiasis by 2020 and attaining elimination as a public health problem (EPHP) by 2025 (now adjusted to 2030 in the new neglected tropical diseases roa
Autor:
Roy M. Anderson, Veronica Malizia, Carolin Vegvari, Sake J. de Vlas, Luc E. Coffeng, Federica Giardina
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 72, S188-S194. Oxford University Press
Clinical Infectious Diseases, 72, S188-S194. Oxford University Press
The design and evaluation of control programs for soil-transmitted helminths (STHs) is based on surveillance data recording measurements of egg counts in the stool of infected individuals, which underpin estimates of the prevalence and average intens
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 105, Iss 4, Pp 598-603 (2010)
The great hope for schistosomiasis treatment began with the development of oxamniquine and praziquantel. These drugs can be administered orally in a single dose and have a high curative power with minor side effects. In this study, we carried out a f
Externí odkaz:
https://doaj.org/article/042e9686d6074bce9765f341ffad5861
Publikováno v:
Parasite, Vol 25, p 54 (2018)
Since 2004, the national schistosomiasis control strategy in China has shifted from the morbidity control strategy (conventional strategy) to an integrated strategy (new strategy). We investigated the effectiveness of the new strategy and compared it
Externí odkaz:
https://doaj.org/article/4a8ecd611c424e98ac215d4187b82946
Autor:
Ana Maria Aguiar-Santos, Marcela Leal-Cruz, Maria José Netto, Arturo Carrera, Guilherme Lima, Abraham Rocha
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 51, Iss 4, Pp 179-183 (2009)
Lymphatic filariasis (LF) causes a wide range of clinical signs and symptoms, including urogenital manifestations. Transmission control and disability/morbidity management/control are the two pillars of the overall elimination strategy for LF. Lymph
Externí odkaz:
https://doaj.org/article/59f99ad9b6654919bd7492b9043b02dd